← Back to Screener
Nature's Sunshine Products Inc. (NATR)
Price$27.34
Favorite Metrics
Price vs S&P 500 (26W)78.77%
Price vs S&P 500 (4W)5.72%
Market Capitalization$478.66M
P/E Ratio (Annual)24.52x
All Metrics
P/CF (Annual)13.55x
Book Value / Share (Quarterly)$9.23
P/TBV (Annual)1.34x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)4.40%
Cash Flow / Share (Quarterly)$1.65
Price vs S&P 500 (YTD)22.55%
Gross Margin (TTM)72.42%
Net Profit Margin (TTM)4.07%
EPS (TTM)$1.05
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$1.05
Revenue Growth (5Y)4.50%
EPS (Annual)$1.06
ROI (Annual)12.08%
Gross Margin (Annual)72.42%
Net Profit Margin (5Y Avg)3.11%
Cash / Share (Quarterly)$5.36
P/E Basic Excl Extra (TTM)24.52x
Revenue Growth QoQ (YoY)4.74%
EPS Growth (5Y)-0.15%
P/E Normalized (Annual)24.52x
ROA (Last FY)7.48%
Revenue Growth TTM (YoY)5.67%
EBITD / Share (TTM)$2.08
ROE (5Y Avg)8.96%
Operating Margin (TTM)5.15%
Cash Flow / Share (Annual)$1.65
P/B Ratio2.96x
P/B Ratio (Quarterly)2.34x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)0.80x
Net Interest Coverage (TTM)12.04x
ROA (TTM)7.56%
EPS Growth QoQ (YoY)28.55%
EV / EBITDA (TTM)9.97x
EPS Incl Extra (Annual)$1.06
Current Ratio (Annual)2.28x
Quick Ratio (Quarterly)1.30x
3-Month Avg Trading Volume0.12M
52-Week Price Return130.13%
EV / Free Cash Flow (Annual)13.34x
P/E Incl Extra (TTM)24.52x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$7.49
P/S Ratio (Annual)1.00x
Asset Turnover (Annual)1.84x
52-Week High$28.14
Operating Margin (5Y Avg)5.09%
EPS Excl Extra (Annual)$1.06
CapEx CAGR (5Y)5.71%
Tangible BV CAGR (5Y)0.65%
26-Week Price Return87.52%
Quick Ratio (Annual)1.30x
13-Week Price Return22.88%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.28x
Enterprise Value$384.767
Revenue / Share Growth (5Y)6.18%
Asset Turnover (TTM)1.86x
Book Value / Share Growth (5Y)3.19%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)2.07x
Pretax Margin (Annual)6.21%
Cash / Share (Annual)$5.36
3-Month Return Std Dev33.63%
Gross Margin (5Y Avg)71.96%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)3.66%
EBITDA Interim CAGR (5Y)5.16%
ROE (Last FY)12.08%
Net Interest Coverage (Annual)0.09x
EPS Basic Excl Extra (Annual)$1.06
P/FCF (TTM)16.60x
Receivables Turnover (TTM)53.12x
EV / Free Cash Flow (TTM)13.34x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$1.05
Receivables Turnover (Annual)53.12x
ROI (TTM)12.18%
P/S Ratio (TTM)1.00x
Pretax Margin (5Y Avg)5.12%
Revenue / Share (Annual)$26.00
Tangible BV / Share (Annual)$6.63
Forward P/E24.41x
Free OCF CAGR (5Y)-2.51%
Price vs S&P 500 (52W)95.04%
P/E Ratio (TTM)24.52x
EPS Growth TTM (YoY)161.09%
Year-to-Date Return26.69%
5-Day Price Return2.21%
EPS Normalized (Annual)$1.06
ROA (5Y Avg)5.54%
Net Profit Margin (Annual)4.07%
Month-to-Date Return13.96%
Cash Flow / Share (TTM)$1.07
EBITD / Share (Annual)$2.09
EPS Growth (3Y)-34.26%
Operating Margin (Annual)5.15%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)13.55x
ROI (5Y Avg)8.90%
P/E Excl Extra (TTM)24.52x
LT Debt / Equity (Quarterly)0.01x
EPS Basic Excl Extra (TTM)$1.05
P/TBV (Quarterly)1.54x
P/B Ratio (Annual)2.34x
Inventory Turnover (TTM)2.07x
Pretax Margin (TTM)6.21%
Book Value / Share (Annual)$9.23
Price vs S&P 500 (13W)20.01%
Net Margin Growth (5Y)-5.95%
Beta0.98x
P/FCF (Annual)16.60x
Revenue / Share (TTM)$26.41
ROE (TTM)12.18%
52-Week Low$11.15
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
NATRNature's Sunshine Products Inc. | 1.00x | 5.67% | 72.42% | -0.15% | $27.34 |
LLYEli Lilly & Co. | 13.44x | 44.70% | 83.04% | 27.59% | $927.03 |
JNJJohnson & Johnson | 5.85x | 7.87% | 67.95% | 14.90% | $234.18 |
ABBVABBVIE INC. | 6.03x | 8.57% | 71.62% | -2.88% | $208.38 |
MRKMerck & Co., Inc. | 4.53x | 1.31% | 78.55% | 21.23% | $119.07 |
AZNAstraZeneca PLC | 5.30x | 8.63% | 81.31% | 21.88% | $204.80 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $151.97 |
NVONovo-Nordisk A/S | 3.70x | 6.43% | 80.98% | 20.66% | $40.52 |
ABTAbbott Laboratories | 3.74x | 6.59% | 56.50% | 8.20% | $96.81 |
PFEPfizer Inc. | 2.51x | -1.64% | 75.81% | -3.51% | $27.56 |
BMYBristol-Myers Squibb Co. | 2.55x | -0.22% | 72.63% | — | $60.17 |
About
Nature's Sunshine Products Inc manufactures and sells nutritional supplements and personal care products targeting weight management, cardiovascular health, digestive wellness, immune support, and general health. The company operates across Asia, Europe, North America, and Latin America, with Asia serving as its largest revenue market.